More Invion Ltd. news
Invion Ltd.ASX: IVX

INV043 significantly improved checkpoint inhibitor therapy

May 29, 2022 at 11:08 PM EDT · Issued by Invion Ltd.

Filed with ASX · May 29, 2022 at 11:08 PM EDT

On 6ix: 6ix.com/news/inv043-significantly-improved-checkpoint-inhibitor-therapy

Invion Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Invion Ltd. on 6ix

Earlier from Invion

  • Supplementary ProspectusNov 25, 2021
  • ProspectusNov 22, 2021
  • Share Purchase Plan Offer Booklet & Application FormNov 21, 2021
  • Capital Raising and expansion of Photosoft TerritoryNov 16, 2021
  • Further Information on Proof of Concept Pilot StudyOct 28, 2021

Later from Invion

  • Activities Report and Appendix 4CJul 20, 2022
  • Photosoft Shows Activity Against Zika VirusSep 7, 2022
  • Response to ASX Aware QuerySep 13, 2022
  • INV043 Effective Against Anal Cancer SCC In VitroSep 14, 2022
  • Expansion of Territory Rights to USA, Canada and Hong KongFeb 7, 2023
All Invion news releases↗

Follow Invion into a list and get an email when it puts out news.

Follow Invion
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer